Article

Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent

Dana Farber Cancer Institute, Phyllis F. Cantor Center, Research in Nursing and Patient Care, Boston, MA, USA. mary
Lung cancer (Amsterdam, Netherlands) (Impact Factor: 3.14). 04/2009; 66(2):218-25. DOI: 10.1016/j.lungcan.2009.01.021
Source: PubMed

ABSTRACT Although it is recommended that smokers undergoing surgery for lung cancer quit smoking to reduce post-operative complications, few studies have examined patterns of smoking in the peri-operative period. The goals of this study were to determine: (1) patterns of smoking during post-operative recovery, (2) types of cessation strategies used to quit smoking, and (3) factors related to smoking after lung cancer surgery.
Data were collected from 94 patients through chart review, tobacco, health status, and symptom questionnaires at 1, 2, and 4 months after surgery. Smoking status was assessed through self-report and urinary cotinine measurement.
Eighty-four patients (89%) were ever-smokers and 35 (37%) reported smoking at diagnosis. Thirty-nine (46%) ever-smokers remained abstinent, 13 (16%) continued smoking at all time-points, and 32 (38%) relapsed. Ten (46%) of those who relapsed were former-smokers and had not smoked for at least 1 year. Sixteen (46%) of those who were smoking at diagnosis received cessation assistance with pharmacotherapy being the most common strategy. Factors associated with smoking during recovery were younger age and quitting smoking < or =6 months before the diagnosis of lung cancer. Factors that were marginally significant were lower educational level, male gender, lower number of comorbidities, and the presence of pain.
Only half of those who were smoking received assistance to quit prior to surgery. Some patients were unable to quit and relapse rates post-surgery were high even among those who quit more than 1 year prior. Innovative programs incorporating symptom management and relapse prevention may enhance smoking abstinence during post-operative care.

1 Bookmark
 · 
124 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Our aim was to explore the experiences and views of complementary therapists (CT) regarding smoking cessation (SC) support within the oncology setting.
    Complementary Therapies in Clinical Practice 08/2014; DOI:10.1016/j.ctcp.2014.07.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective The aim of this study was to investigate the smoking status of lung cancer patients and to confirm the risk of smoking for patients undergoing lung cancer surgery. Methods We conducted a retrospective study of patients undergoing lung cancer surgery. Between May 2004 and March 2013, 716 patients underwent lung cancer surgery at our institution. Based on smoking status, the patients were classified into 3 groups: nonsmoker, past smoker, and current smoker. Based on exclusion criteria, a final total of 670 patients were investigated for the association between smoking status and postoperative complications. In addition, we explored the effect of smoking on survival after surgery. Results There were 254 non-smokers, 246 past smokers, and 170 current smokers. The percent of female patients, adenocarcinoma, and stage IA cancer was highest in the nonsmokers. Respiratory function was significantly impaired in past and current smokers. Respiratory and cardiac complications were found less frequently in non-smokers (11.4 %) followed by 17.1 % of past smokers and 21.2 % of current smokers (p = 0.0226). Univariate analysis showed that smoking was a significantly poor prognostic factor for overall survival. The 5-year survival rates for non-smokers, past, and current smokers were 81.4, 65.4, and 68.8 %, respectively (p = 0.0003). Conclusions Smokers with lung cancer tended to have advanced lung cancer, impaired pulmonary function, and high morbidity after lung cancer surgery. Although multivariate analysis did not show that smoking was associated with poor outcome, non-smokers had significantly better overall survival, even for patients with stage IA lung cancers.
    General Thoracic and Cardiovascular Surgery 08/2014; 63(2). DOI:10.1007/s11748-014-0461-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose/Objectives: To test the feasibility of a multidisciplinary, multicomponent, theory-based decision aid. Design: Prospective, one-group repeated measures. Setting: Thoracic surgery clinic in a university hospital cancer center in central Virginia. Sample: 8 dyads, consisting of 16 total participants. Methods: A multidisciplinary, multicomponent smoking cessation intervention incorporated a theory-based decision aid. Enrollment occurred preoperatively; four face-to-face visits and an exit interview were conducted during six months. Main Research Variables: Feasibility was evaluated based on four criteria: recruitment, retention, adherence, and acceptability. Findings: The recruitment rate was 44%, and the retention rate was 100%. Adherence to the intervention and the acceptability of the decision aid were greater for patients than family members. Patients had greater abstinence than family members before surgery and at six months. Exit interview themes included (a) preoperative timing was acceptable and (b) involving household members who smoke was important. Conclusions: Recruiting male patients and their female partners is feasible. Participants liked convenience, autonomy, and a family approach. Family members wanted more control over cessation timing and a more intensive approach to weight and mental health management. Successful dyads worked together to maintain abstinence. Implications for Nursing: Oncology nurses can assess patients' and family members' smoking status, facilitate understanding about specific benefits of smoking cessation and the obstacle posed by household smokers, and make referrals to expert resources. Encouraging smoke-free environments is an important step toward reducing secondhand smoke exposure and promoting cessation.
    Oncology nursing forum 11/2014; 41(6):649-58. DOI:10.1188/14.ONF.649-658 · 2.83 Impact Factor